Eternal Material Technology: Driving Digital Transformation with iLabPower and AI Integration

About Eternal Material Technology

Beijing Eternal Material Technology Co., Ltd. (EMT) is a leading high-tech enterprise specializing in the R&D, production, and sales of advanced electronic materials. Focused on innovations in tablet display and optoelectronics, EMT holds a prominent industry position, particularly in OLED materials and photoresist materials. Recognized as a China National High-Tech Enterprise and a “Little Giant” in specialized manufacturing, EMT is committed to advancing the technology and product services of new materials.

Challenges faced by EMT

  • Management of large volumes of locally stored, spreadsheet-based data.
  • Difficulties in tracking project progress efficiently.
  • Lack of refined management for instruments and reagents.
  • Need for multi-dimensional analysis of batch data.
  • OLED material development relies heavily on trial-and-error experiments, with inconsistent data quality and missing key photoelectric and structural information, hindering the iterative development of new materials and limiting industrial transformation efforts.

Our Solution

In early 2022, EMT partnered with Neotrident Technology to implement the iLabPower R&D digital platform, incorporating iLabPower Project Management (PM), Electronic Lab Notebook (ELN), Chemical Inventory Management (CIMS), Compound Management (RegMS), Instrument Management (IM), Scientific Data Genome (SDH), and the MaXFlow molecular simulation and AI platform. This comprehensive system integrates data acquisition, integration, and simulation to optimize R&D processes.

Key Objectives and Solutions

  1. iLabPower R&D Innovation Digital Platform:
    Anchored by ELN, the iLabPower platform integrates data across all modules, optimizing EMT’s scientific research management workflows. It standardizes project and experimental data records, refines material management, and boosts overall laboratory efficiency. The PM system enables real-time project tracking, while ELN ensures standardized scientific data management. CIMS and IM provide life-cycle management of materials and instruments, including dynamic tracking of inventory, hazardous reagent approvals, and usage logs. CMS manages compound synthesis data, analysis, and spectra, enhancing data accessibility and usability.
  2. Scientific Data Hierarchy (SDH):
    SDH integrates data from iLabPower, historical spreadsheets, and external databases, allowing scientists to link and categorize core R&D data without coding. This tool eliminates data silos, improves data utilization, and frees scientists from time-consuming manual analysis.
  3. Molecular Simulation and AI Platform (MaXFlow):
    Utilizing deep learning, MaXFlow analyzes vast material data to identify patterns, decipher structure-performance relationships, and enable rational material design. This reduces trial-and-error costs and enhances predictive accuracy for material properties.

Benefits & Achievements

  • Enhanced linkage between R&D projects and experimental data, facilitating structured data management.
  • Online recording and sharing of experimental processes and observations across projects, improving data utilization rates.
  • Full life-cycle management of instruments and materials, integrating performance evaluation and property analysis data.
  • Elimination of isolated data silos, enabling comprehensive data integration.
  • Machine learning models developed with MaXFlow identified the relationship between the external quantum efficiency (EQE) of OLEDs and molecular/device structures. From 1,000 device data points and 800 molecular structures, the model reduced features to 35, achieved an RMSE of 3.21%, and successfully predicted EQE performance, positioning EMT at the forefront of commercializing advanced materials.

By leveraging digital transformation with Neotrident’s iLabPower and AI platforms, EMT significantly enhances R&D capabilities, supports industrial transformation, and strengthens its competitive edge in the global market.

Comments are closed.